Biblio Discovery — Demo Discovery Service

18 hasil untuk "Burger, Angelika M"

Menampilkan 1–18 · 0,81 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Therapeutic Implications of Leukemic Stem Cell Pathways

    Chumsri, Saranya; Matsui, William; Burger, Angelika M.

    Clin Cancer Res · 2007 · Inggris · PubMed Central

    An emerging concept in cancer biology is that a rare population of cancer stem cells exists among the heterogeneous cell mass that constitutes a tumor. This concept is best understood in human myeloid leukemia. Normal and malignant hematopoietic stem cell functions are defined by a common set of…

  2. Artikel Jurnal Teks lengkap

    Homology Modelling of Human E1 Ubiquitin Activating Enzyme

    Brahemi, Ghali; Burger, Angelika M.; Westwell, Andrew D. dkk.

    Lett Drug Des Discov · 2010 · Inggris · PubMed Central

    Human E1 is a key player in protein ubiquitination, however the E1 structure is not available. In this paper, we describe the derivation of a human E1 structure using molecular modelling based on the crystal structure of S. cerevisiae E1 and M. Musculus E1. Key interactions between our E1 model and…

  3. Artikel Jurnal Teks lengkap

    Tissue Microarrays of Human Tumor Xenografts: Characterization of Proteins Involved in Migration and Angiogenesis for Applications in the Development of Targeted Anticancer Agents

    Smith, Victoria; Wirth, Gregory J.; Fiebig, Heinz-Herbert dkk.

    Cancer Genomics Proteomics · 2008 · Inggris · PubMed Central

    As new target-directed anticancer agents emerge, preclinical efficacy studies need to integrate target-driven model systems. This approach to drug development requires rapid and reliable characterization of the new targets in established tumor models, such as xenografts and cell lines. Here, we…

  4. Artikel Jurnal Teks lengkap

    Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer

    Burger, Angelika M.; Kona, Fathima; Amemiya, Yutaka dkk.

    Open Cancer J · 2010 · Inggris · PubMed Central

    The BCA2 protein contains a RING H2 finger and a Zn finger near the N-terminus and has E3 ligase activity. RING finger proteins play critical roles in mediating the transfer of ubiquitin and ubiquitin like modifiers to heterologous substrates as well as to the RING finger proteins themselves…

  5. Artikel Jurnal Teks lengkap

    Targetable HPMA Copolymer–Aminohexylgeldanamycin Conjugates for Prostate Cancer Therapy

    Borgman, Mark P.; Ray, Abhijit; Kolhatkar, Rohit B. dkk.

    Pharm Res · 2009 · Inggris · PubMed Central

    PURPOSE: This study focuses on the synthesis and characterization of N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer–cyclo-RGD (Arg-Gly-Asp) conjugates for delivery of geldanamycin to prostate tumors. MATERIALS AND METHODS: HPMA copolymers containing aminohexylgeldanamycin (AH-GDM) with and…

  6. Artikel Jurnal Teks lengkap

    17α-Hydroxylase/17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response

    Bruno, Robert D.; Gover, Tony D.; Burger, Angelika M. dkk.

    Mol Cancer Ther · 2008 · Inggris · PubMed Central

    Inhibitors of the enzyme 17α-hydroxylase/17,20 lyase are a new class of anti–prostate cancer agents currently undergoing preclinical and clinical development. We have previously reported the superior anticancer activity of our novel 17α-hydroxylase/17,20 lyase inhibitor, VN/124-1, against…

  7. Artikel Jurnal Teks lengkap

    HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas

    Sosin, Angela M; Burger, Angelika M; Siddiqi, Aisha dkk.

    J Hematol Oncol · 2012 · Inggris · PubMed Central

    BACKGROUND: Lymphomas frequently retain wild-type (wt) p53 function but overexpress HDM2, thereby compromising p53 activity. Therefore, lymphoma is a suitable model for studying the therapeutic value of disrupting the HDM2-p53 interaction by small-molecule inhibitors (SMIs). HDM2 have been…

    Juga tersedia di: DOAJ

  8. Artikel Jurnal Teks lengkap

    Aminoflavone, a ligand of the Aryl Hydrocarbon Receptor (AhR), inhibits HIF-1α expression in an AhR-independent fashion

    Terzuoli, Erika; Puppo, Maura; Rapisarda, Annamaria dkk.

    Cancer Res · 2010 · Inggris · PubMed Central

    Aminoflavone (AF), the active component of a novel anticancer agent (AFP464) in phase I clinical trials, is a ligand of the aryl hydrocarbon receptor (AhR). AhR dimerizes with HIF-1β/ARNT, which is shared with HIF-1α, a transcription factor critical for the response of cells to oxygen deprivation…

  9. Artikel Jurnal Teks lengkap

    Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate

    Duncan, Ruth; Sat-Klopsch, Yee-Nee; Burger, Angelika M. dkk.

    Cancer Chemother Pharmacol · 2013 · Inggris · PubMed Central

    PURPOSE: Intravenously (i.v.) administered nanomedicines have the potential for tumour targeting due to the enhanced permeability and retention (EPR) effect, but in vivo tumour models are rarely calibrated with respect to functional vascular permeability and/or mechanisms controlling intratumoural…

  10. Artikel Jurnal Teks lengkap

    Exploring the Structural Requirements for Inhibition of the Ubiquitin E3 Ligase Breast Cancer Associated Protein 2 (BCA2) as a Treatment for Breast Cancer

    Brahemi, Ghali; Kona, Fathima R.; Fiasella, Annalisa dkk.

    J Med Chem · 2010 · Inggris · PubMed Central

    The zinc-ejecting aldehyde dehydrogenase (ALDH) inhibitory drug disulfiram (DSF) was found to be a breast cancer-associated protein 2 (BCA2) inhibitor with potent antitumor activity. We herein describe our work in the synthesis and evaluation of new series of zinc-affinic molecules to explore the…

  11. Artikel Jurnal Teks lengkap

    EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance

    Zhang, Yuexing; Linn, Douglas; Liu, Zhenqiu dkk.

    Mol Cancer Ther · 2008 · Inggris · PubMed Central

    Aberrant activation of the androgen receptor (AR) by the ErbB2/ErbB3 heterodimer contributes to the development of hormone resistance in prostate cancer. EBP1, an ErbB3-binding protein, acts as an AR corepressor. As EBP1 is decreased in preclinical models of hormone-refractory prostate cancer, we…

  12. Artikel Jurnal Teks lengkap

    The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase

    Schrader, Mark; Burger, Angelika M; Müller, Markus dkk.

    BMC Cancer · 2002 · Inggris · PubMed Central

    BACKGROUND: The activity of the ribonucleoprotein enzyme telomerase is detectable in germ, stem and tumor cells. One major component of telomerase is human telomerase reverse transcriptase (hTERT), which encodes the catalytic subunit of telomerase. Here we investigate the correlation of telomerase…

    Juga tersedia di: DOAJ

  13. Artikel Jurnal Teks lengkap

    A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells

    Linn, Douglas E.; Yang, Xi; Sun, Feng dkk.

    Genes Cancer · 2010 · Inggris · PubMed Central

    Drug resistance remains a clinical challenge in cancer treatment due to poor understanding of underlying mechanisms. We have established several drug-resistant prostate cancer cell lines by long-term culture in medium containing chemotherapeutic drugs. These resistant lines displayed a significant…

  14. Artikel Jurnal Teks lengkap

    SAFETY, EFFICACY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE COMBINATION OF SORAFENIB AND TANESPIMYCIN

    Vaishampayan, Ulka N.; Burger, Angelika M.; Sausville, Edward A. dkk.

    Clin Cancer Res · 2010 · Inggris · PubMed Central

    PURPOSE: Heat shock protein 90 inhibition affects the Raf-kinase signaling pathway and could enhance anti-tumor effects of sorafenib, a Raf-kinase inhibitor. The combination of sorafenib and tanespimycin (17-AAG/17-allyl-amino-geldanamycin; NSC # 330507/KOS-953) was evaluated in a phase I trial…

  15. Artikel Jurnal Teks lengkap

    Phase I Study Of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma

    Badros, Ashraf; Burger, Angelika M.; Philip, Sunita dkk.

    Clin Cancer Res · 2009 · Inggris · PubMed Central

    PURPOSE: Vorinostat, a histone deacetylase inhibitor, enhances cell death by the proteasome inhibitor bortezomib in vitro. We sought to test the combination clinically. EXPERIMENTAL DESIGN: A phase I trial evaluated sequential dose escalation of bortezomib at 1– 1.3 mg/ m(2) intravenously on days…

  16. Artikel Jurnal Teks lengkap

    Antitumor Activity of Bis-Indole Derivatives

    Andreani, Aldo; Burnelli, Silvia; Granaiola, Massimiliano dkk.

    J Med Chem · 2008 · Inggris · PubMed Central

    This paper reports the synthesis of compounds formed by two indole systems separated by a heterocycle (pyridine or piperazine). As a primary screening, the new compounds were submitted to the National Cancer Institute for evaluation of antitumor activity in the human cell line screen. The pyridine…